nodes	percent_of_prediction	percent_of_DWPC	metapath
Paclitaxel—breast cancer—colon cancer	0.177	0.408	CtDrD
Paclitaxel—ovarian cancer—colon cancer	0.143	0.328	CtDrD
Paclitaxel—lung cancer—colon cancer	0.115	0.265	CtDrD
Paclitaxel—ABCB1—colon cancer	0.0702	1	CbGaD
Paclitaxel—TUBB6—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB8—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB2B—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB2A—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB3—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB4A—Vincristine—colon cancer	0.0266	0.076	CbGbCtD
Paclitaxel—TUBB4B—Vincristine—colon cancer	0.0222	0.0636	CbGbCtD
Paclitaxel—TUBB1—Vincristine—colon cancer	0.0222	0.0636	CbGbCtD
Paclitaxel—TUBB—Vincristine—colon cancer	0.0222	0.0636	CbGbCtD
Paclitaxel—ABCC10—Vincristine—colon cancer	0.017	0.0486	CbGbCtD
Paclitaxel—ABCC10—Methotrexate—colon cancer	0.0103	0.0294	CbGbCtD
Paclitaxel—ABCB11—Vincristine—colon cancer	0.00923	0.0264	CbGbCtD
Paclitaxel—ABCC1—Irinotecan—colon cancer	0.0075	0.0215	CbGbCtD
Paclitaxel—ABCC1—Vincristine—colon cancer	0.00656	0.0188	CbGbCtD
Paclitaxel—SLCO1B3—Methotrexate—colon cancer	0.00574	0.0164	CbGbCtD
Paclitaxel—ABCC2—Irinotecan—colon cancer	0.00555	0.0159	CbGbCtD
Paclitaxel—ABCG2—Irinotecan—colon cancer	0.00502	0.0144	CbGbCtD
Paclitaxel—ABCC2—Vincristine—colon cancer	0.00485	0.0139	CbGbCtD
Paclitaxel—ABCG2—Fluorouracil—colon cancer	0.00482	0.0138	CbGbCtD
Paclitaxel—ABCG2—Vincristine—colon cancer	0.00439	0.0126	CbGbCtD
Paclitaxel—ABCC1—Methotrexate—colon cancer	0.00397	0.0114	CbGbCtD
Paclitaxel—CYP3A7—Irinotecan—colon cancer	0.00371	0.0106	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.00371	0.0106	CbGbCtD
Paclitaxel—CYP3A7—Vincristine—colon cancer	0.00324	0.00927	CbGbCtD
Paclitaxel—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.00324	0.00927	CbGbCtD
Paclitaxel—CYP2C9—Capecitabine—colon cancer	0.00302	0.00864	CbGbCtD
Paclitaxel—ABCC2—Methotrexate—colon cancer	0.00294	0.00841	CbGbCtD
Paclitaxel—ABCB11—bile—colon cancer	0.0029	0.0963	CbGeAlD
Paclitaxel—CYP3A5—Irinotecan—colon cancer	0.00278	0.00796	CbGbCtD
Paclitaxel—ABCG2—Methotrexate—colon cancer	0.00266	0.0076	CbGbCtD
Paclitaxel—CYP2C8—Fluorouracil—colon cancer	0.00257	0.00734	CbGbCtD
Paclitaxel—CYP3A5—Vincristine—colon cancer	0.00243	0.00696	CbGbCtD
Paclitaxel—ABCB1—Irinotecan—colon cancer	0.00181	0.00518	CbGbCtD
Paclitaxel—CYP2C9—Fluorouracil—colon cancer	0.00179	0.00512	CbGbCtD
Paclitaxel—ABCB1—Vincristine—colon cancer	0.00158	0.00453	CbGbCtD
Paclitaxel—ABCC2—bile—colon cancer	0.00148	0.049	CbGeAlD
Paclitaxel—CYP3A4—Irinotecan—colon cancer	0.00108	0.0031	CbGbCtD
Paclitaxel—ABCB1—Methotrexate—colon cancer	0.000958	0.00274	CbGbCtD
Paclitaxel—CYP3A4—Vincristine—colon cancer	0.000948	0.00271	CbGbCtD
Paclitaxel—Docetaxel—EGFR—colon cancer	0.000877	0.595	CrCbGaD
Paclitaxel—MAP4—embryo—colon cancer	0.000676	0.0224	CbGeAlD
Paclitaxel—NR1I2—digestive system—colon cancer	0.000642	0.0213	CbGeAlD
Paclitaxel—MAP2—embryo—colon cancer	0.000533	0.0177	CbGeAlD
Paclitaxel—MAP4—renal system—colon cancer	0.000512	0.017	CbGeAlD
Paclitaxel—BCL2—epithelium—colon cancer	0.000502	0.0166	CbGeAlD
Paclitaxel—BCL2—smooth muscle tissue—colon cancer	0.000483	0.016	CbGeAlD
Paclitaxel—NR1I2—liver—colon cancer	0.000478	0.0159	CbGeAlD
Paclitaxel—BCL2—renal system—colon cancer	0.000465	0.0154	CbGeAlD
Paclitaxel—TUBB3—lymphoid tissue—colon cancer	0.000425	0.0141	CbGeAlD
Paclitaxel—MAP4—lymphoid tissue—colon cancer	0.000425	0.0141	CbGeAlD
Paclitaxel—TUBB3—digestive system—colon cancer	0.00042	0.0139	CbGeAlD
Paclitaxel—MAP4—digestive system—colon cancer	0.00042	0.0139	CbGeAlD
Paclitaxel—TUBB4A—embryo—colon cancer	0.000412	0.0137	CbGeAlD
Paclitaxel—BCL2—lymphoid tissue—colon cancer	0.000386	0.0128	CbGeAlD
Paclitaxel—BCL2—digestive system—colon cancer	0.000382	0.0127	CbGeAlD
Paclitaxel—TUBB1—bone marrow—colon cancer	0.000378	0.0126	CbGeAlD
Paclitaxel—MAP4—vagina—colon cancer	0.000371	0.0123	CbGeAlD
Paclitaxel—BCL2—bone marrow—colon cancer	0.000352	0.0117	CbGeAlD
Paclitaxel—MAP2—digestive system—colon cancer	0.000331	0.011	CbGeAlD
Paclitaxel—Cabazitaxel—ABCB1—colon cancer	0.00033	0.224	CrCbGaD
Paclitaxel—SLCO1B3—vagina—colon cancer	0.000325	0.0108	CbGeAlD
Paclitaxel—TUBB4B—embryo—colon cancer	0.000321	0.0107	CbGeAlD
Paclitaxel—ABCB11—digestive system—colon cancer	0.000317	0.0105	CbGeAlD
Paclitaxel—MAP4—liver—colon cancer	0.000313	0.0104	CbGeAlD
Paclitaxel—TUBB4A—renal system—colon cancer	0.000312	0.0103	CbGeAlD
Paclitaxel—MAPT—lymph node—colon cancer	0.000305	0.0101	CbGeAlD
Paclitaxel—TUBB6—epithelium—colon cancer	0.000301	0.01	CbGeAlD
Paclitaxel—TUBB2B—renal system—colon cancer	0.000301	0.00999	CbGeAlD
Paclitaxel—TUBB—smooth muscle tissue—colon cancer	0.000296	0.00982	CbGeAlD
Paclitaxel—TUBB2A—smooth muscle tissue—colon cancer	0.000294	0.00977	CbGeAlD
Paclitaxel—MAP2—vagina—colon cancer	0.000292	0.00969	CbGeAlD
Paclitaxel—TUBB6—smooth muscle tissue—colon cancer	0.00029	0.00964	CbGeAlD
Paclitaxel—TUBB6—renal system—colon cancer	0.00028	0.00928	CbGeAlD
Paclitaxel—SLCO1B3—liver—colon cancer	0.000274	0.00909	CbGeAlD
Paclitaxel—Docetaxel—ABCB1—colon cancer	0.000267	0.181	CrCbGaD
Paclitaxel—TUBB4A—lymphoid tissue—colon cancer	0.000259	0.00858	CbGeAlD
Paclitaxel—TUBB4A—digestive system—colon cancer	0.000255	0.00848	CbGeAlD
Paclitaxel—TUBB4B—smooth muscle tissue—colon cancer	0.000252	0.00838	CbGeAlD
Paclitaxel—TUBB2B—digestive system—colon cancer	0.000247	0.00819	CbGeAlD
Paclitaxel—MAP2—liver—colon cancer	0.000246	0.00817	CbGeAlD
Paclitaxel—ABCC10—renal system—colon cancer	0.000245	0.00812	CbGeAlD
Paclitaxel—TUBB4B—renal system—colon cancer	0.000243	0.00806	CbGeAlD
Paclitaxel—MAP4—lymph node—colon cancer	0.00024	0.00796	CbGeAlD
Paclitaxel—ABCB11—liver—colon cancer	0.000236	0.00784	CbGeAlD
Paclitaxel—TUBB2A—digestive system—colon cancer	0.000232	0.00771	CbGeAlD
Paclitaxel—TUBB6—lymphoid tissue—colon cancer	0.000232	0.0077	CbGeAlD
Paclitaxel—CYP3A7—liver—colon cancer	0.000231	0.00766	CbGeAlD
Paclitaxel—TUBB6—digestive system—colon cancer	0.000229	0.00761	CbGeAlD
Paclitaxel—TUBB2B—vagina—colon cancer	0.000218	0.00724	CbGeAlD
Paclitaxel—BCL2—lymph node—colon cancer	0.000218	0.00723	CbGeAlD
Paclitaxel—TUBB—bone marrow—colon cancer	0.000215	0.00715	CbGeAlD
Paclitaxel—TUBB2A—bone marrow—colon cancer	0.000214	0.00711	CbGeAlD
Paclitaxel—TUBB6—bone marrow—colon cancer	0.000211	0.00701	CbGeAlD
Paclitaxel—TUBB—vagina—colon cancer	0.000206	0.00685	CbGeAlD
Paclitaxel—TUBB2A—vagina—colon cancer	0.000205	0.00681	CbGeAlD
Paclitaxel—ABCC10—lymphoid tissue—colon cancer	0.000203	0.00674	CbGeAlD
Paclitaxel—TUBB6—vagina—colon cancer	0.000202	0.00672	CbGeAlD
Paclitaxel—TUBB4B—lymphoid tissue—colon cancer	0.000202	0.00669	CbGeAlD
Paclitaxel—ABCC10—digestive system—colon cancer	0.000201	0.00666	CbGeAlD
Paclitaxel—CYP1B1—smooth muscle tissue—colon cancer	0.0002	0.00663	CbGeAlD
Paclitaxel—TUBB4B—digestive system—colon cancer	0.000199	0.00661	CbGeAlD
Paclitaxel—ABCC2—renal system—colon cancer	0.000197	0.00652	CbGeAlD
Paclitaxel—CYP3A7-CYP3A51P—liver—colon cancer	0.000196	0.00652	CbGeAlD
Paclitaxel—CYP1B1—renal system—colon cancer	0.000192	0.00639	CbGeAlD
Paclitaxel—TUBB4A—liver—colon cancer	0.00019	0.00632	CbGeAlD
Paclitaxel—MAP2—lymph node—colon cancer	0.000189	0.00627	CbGeAlD
Paclitaxel—ABCC10—bone marrow—colon cancer	0.000185	0.00614	CbGeAlD
Paclitaxel—TUBB4B—bone marrow—colon cancer	0.000184	0.0061	CbGeAlD
Paclitaxel—ABCC10—vagina—colon cancer	0.000177	0.00588	CbGeAlD
Paclitaxel—TUBB4B—vagina—colon cancer	0.000176	0.00584	CbGeAlD
Paclitaxel—TUBB—liver—colon cancer	0.000174	0.00578	CbGeAlD
Paclitaxel—TUBB2A—liver—colon cancer	0.000173	0.00575	CbGeAlD
Paclitaxel—TUBB6—liver—colon cancer	0.000171	0.00567	CbGeAlD
Paclitaxel—ABCC2—digestive system—colon cancer	0.000161	0.00535	CbGeAlD
Paclitaxel—CYP1B1—lymphoid tissue—colon cancer	0.00016	0.0053	CbGeAlD
Paclitaxel—CYP1B1—digestive system—colon cancer	0.000158	0.00524	CbGeAlD
Paclitaxel—ABCB1—blood vessel—colon cancer	0.000157	0.00519	CbGeAlD
Paclitaxel—ABCC10—liver—colon cancer	0.00015	0.00496	CbGeAlD
Paclitaxel—TUBB4B—liver—colon cancer	0.000148	0.00493	CbGeAlD
Paclitaxel—CYP2C8—renal system—colon cancer	0.000147	0.00489	CbGeAlD
Paclitaxel—TUBB4A—lymph node—colon cancer	0.000146	0.00484	CbGeAlD
Paclitaxel—TUBB2B—lymph node—colon cancer	0.000141	0.00468	CbGeAlD
Paclitaxel—TUBB—lymph node—colon cancer	0.000133	0.00443	CbGeAlD
Paclitaxel—CYP3A5—renal system—colon cancer	0.000133	0.00441	CbGeAlD
Paclitaxel—TUBB2A—lymph node—colon cancer	0.000133	0.00441	CbGeAlD
Paclitaxel—TUBB6—lymph node—colon cancer	0.000131	0.00435	CbGeAlD
Paclitaxel—CYP19A1—liver—colon cancer	0.000126	0.00417	CbGeAlD
Paclitaxel—ABCC1—vagina—colon cancer	0.000125	0.00416	CbGeAlD
Paclitaxel—ABCC2—liver—colon cancer	0.00012	0.00398	CbGeAlD
Paclitaxel—CYP1B1—liver—colon cancer	0.000118	0.0039	CbGeAlD
Paclitaxel—ABCC10—lymph node—colon cancer	0.000115	0.0038	CbGeAlD
Paclitaxel—TUBB4B—lymph node—colon cancer	0.000114	0.00378	CbGeAlD
Paclitaxel—CYP3A5—digestive system—colon cancer	0.000109	0.00362	CbGeAlD
Paclitaxel—ABCG2—bone marrow—colon cancer	0.000108	0.0036	CbGeAlD
Paclitaxel—CYP2C9—digestive system—colon cancer	0.000107	0.00356	CbGeAlD
Paclitaxel—CYP2C8—vagina—colon cancer	0.000107	0.00354	CbGeAlD
Paclitaxel—ABCC1—liver—colon cancer	0.000106	0.00351	CbGeAlD
Paclitaxel—ABCG2—vagina—colon cancer	0.000104	0.00344	CbGeAlD
Paclitaxel—CYP3A4—renal system—colon cancer	9.98e-05	0.00331	CbGeAlD
Paclitaxel—CYP19A1—lymph node—colon cancer	9.64e-05	0.0032	CbGeAlD
Paclitaxel—CYP3A5—vagina—colon cancer	9.64e-05	0.0032	CbGeAlD
Paclitaxel—ABCB1—embryo—colon cancer	9.34e-05	0.0031	CbGeAlD
Paclitaxel—ABCC2—lymph node—colon cancer	9.21e-05	0.00305	CbGeAlD
Paclitaxel—CYP1B1—lymph node—colon cancer	9.02e-05	0.00299	CbGeAlD
Paclitaxel—CYP2C8—liver—colon cancer	9.01e-05	0.00299	CbGeAlD
Paclitaxel—ABCG2—liver—colon cancer	8.76e-05	0.00291	CbGeAlD
Paclitaxel—CYP3A4—digestive system—colon cancer	8.19e-05	0.00272	CbGeAlD
Paclitaxel—CYP3A5—liver—colon cancer	8.13e-05	0.0027	CbGeAlD
Paclitaxel—ABCC1—lymph node—colon cancer	8.11e-05	0.00269	CbGeAlD
Paclitaxel—CYP2C9—liver—colon cancer	8e-05	0.00265	CbGeAlD
Paclitaxel—ABCB1—epithelium—colon cancer	7.62e-05	0.00253	CbGeAlD
Paclitaxel—ABCB1—renal system—colon cancer	7.07e-05	0.00234	CbGeAlD
Paclitaxel—ABCG2—lymph node—colon cancer	6.71e-05	0.00223	CbGeAlD
Paclitaxel—CYP3A4—liver—colon cancer	6.1e-05	0.00202	CbGeAlD
Paclitaxel—ABCB1—lymphoid tissue—colon cancer	5.87e-05	0.00195	CbGeAlD
Paclitaxel—ABCB1—digestive system—colon cancer	5.8e-05	0.00192	CbGeAlD
Paclitaxel—ABCB1—bone marrow—colon cancer	5.34e-05	0.00177	CbGeAlD
Paclitaxel—ABCB1—vagina—colon cancer	5.12e-05	0.0017	CbGeAlD
Paclitaxel—Hyperhidrosis—Irinotecan—colon cancer	4.47e-05	0.000583	CcSEcCtD
Paclitaxel—Confusional state—Fluorouracil—colon cancer	4.47e-05	0.000582	CcSEcCtD
Paclitaxel—Mood swings—Methotrexate—colon cancer	4.44e-05	0.000579	CcSEcCtD
Paclitaxel—Hypotension—Vincristine—colon cancer	4.44e-05	0.000579	CcSEcCtD
Paclitaxel—Bradycardia—Capecitabine—colon cancer	4.44e-05	0.000578	CcSEcCtD
Paclitaxel—Anaphylactic shock—Fluorouracil—colon cancer	4.43e-05	0.000578	CcSEcCtD
Paclitaxel—Oedema—Fluorouracil—colon cancer	4.43e-05	0.000578	CcSEcCtD
Paclitaxel—Anorexia—Irinotecan—colon cancer	4.41e-05	0.000575	CcSEcCtD
Paclitaxel—Ataxia—Methotrexate—colon cancer	4.41e-05	0.000575	CcSEcCtD
Paclitaxel—Infection—Fluorouracil—colon cancer	4.4e-05	0.000574	CcSEcCtD
Paclitaxel—Haemoglobin—Capecitabine—colon cancer	4.38e-05	0.000571	CcSEcCtD
Paclitaxel—Rhinitis—Capecitabine—colon cancer	4.37e-05	0.000569	CcSEcCtD
Paclitaxel—Haemorrhage—Capecitabine—colon cancer	4.36e-05	0.000568	CcSEcCtD
Paclitaxel—Nervous system disorder—Fluorouracil—colon cancer	4.35e-05	0.000566	CcSEcCtD
Paclitaxel—Thrombocytopenia—Fluorouracil—colon cancer	4.34e-05	0.000565	CcSEcCtD
Paclitaxel—Hypoaesthesia—Capecitabine—colon cancer	4.34e-05	0.000565	CcSEcCtD
Paclitaxel—Liver function test abnormal—Methotrexate—colon cancer	4.33e-05	0.000564	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Vincristine—colon cancer	4.33e-05	0.000564	CcSEcCtD
Paclitaxel—Pharyngitis—Capecitabine—colon cancer	4.33e-05	0.000564	CcSEcCtD
Paclitaxel—Tachycardia—Fluorouracil—colon cancer	4.33e-05	0.000564	CcSEcCtD
Paclitaxel—Hypotension—Irinotecan—colon cancer	4.32e-05	0.000563	CcSEcCtD
Paclitaxel—ABCB1—liver—colon cancer	4.32e-05	0.00143	CbGeAlD
Paclitaxel—Urinary tract disorder—Capecitabine—colon cancer	4.31e-05	0.000561	CcSEcCtD
Paclitaxel—Insomnia—Vincristine—colon cancer	4.3e-05	0.00056	CcSEcCtD
Paclitaxel—Oedema peripheral—Capecitabine—colon cancer	4.29e-05	0.00056	CcSEcCtD
Paclitaxel—Connective tissue disorder—Capecitabine—colon cancer	4.28e-05	0.000558	CcSEcCtD
Paclitaxel—Urethral disorder—Capecitabine—colon cancer	4.27e-05	0.000557	CcSEcCtD
Paclitaxel—Paraesthesia—Vincristine—colon cancer	4.27e-05	0.000556	CcSEcCtD
Paclitaxel—Breast disorder—Methotrexate—colon cancer	4.24e-05	0.000552	CcSEcCtD
Paclitaxel—Anorexia—Fluorouracil—colon cancer	4.22e-05	0.00055	CcSEcCtD
Paclitaxel—Toxic epidermal necrolysis—Methotrexate—colon cancer	4.22e-05	0.00055	CcSEcCtD
Paclitaxel—Visual impairment—Capecitabine—colon cancer	4.2e-05	0.000547	CcSEcCtD
Paclitaxel—Insomnia—Irinotecan—colon cancer	4.19e-05	0.000545	CcSEcCtD
Paclitaxel—Paraesthesia—Irinotecan—colon cancer	4.16e-05	0.000541	CcSEcCtD
Paclitaxel—Hypotension—Fluorouracil—colon cancer	4.14e-05	0.00054	CcSEcCtD
Paclitaxel—Decreased appetite—Vincristine—colon cancer	4.13e-05	0.000538	CcSEcCtD
Paclitaxel—Dyspnoea—Irinotecan—colon cancer	4.13e-05	0.000538	CcSEcCtD
Paclitaxel—Erythema multiforme—Capecitabine—colon cancer	4.12e-05	0.000537	CcSEcCtD
Paclitaxel—Somnolence—Irinotecan—colon cancer	4.11e-05	0.000536	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Vincristine—colon cancer	4.1e-05	0.000535	CcSEcCtD
Paclitaxel—Fatigue—Vincristine—colon cancer	4.1e-05	0.000534	CcSEcCtD
Paclitaxel—Eye disorder—Capecitabine—colon cancer	4.07e-05	0.000531	CcSEcCtD
Paclitaxel—Dyspepsia—Irinotecan—colon cancer	4.07e-05	0.000531	CcSEcCtD
Paclitaxel—Tinnitus—Capecitabine—colon cancer	4.06e-05	0.00053	CcSEcCtD
Paclitaxel—Constipation—Vincristine—colon cancer	4.06e-05	0.000529	CcSEcCtD
Paclitaxel—Pain—Vincristine—colon cancer	4.06e-05	0.000529	CcSEcCtD
Paclitaxel—Flushing—Capecitabine—colon cancer	4.05e-05	0.000527	CcSEcCtD
Paclitaxel—Cardiac disorder—Capecitabine—colon cancer	4.05e-05	0.000527	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Fluorouracil—colon cancer	4.04e-05	0.000526	CcSEcCtD
Paclitaxel—Decreased appetite—Irinotecan—colon cancer	4.02e-05	0.000524	CcSEcCtD
Paclitaxel—Insomnia—Fluorouracil—colon cancer	4.01e-05	0.000522	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Irinotecan—colon cancer	4e-05	0.000521	CcSEcCtD
Paclitaxel—Fatigue—Irinotecan—colon cancer	3.99e-05	0.00052	CcSEcCtD
Paclitaxel—Paraesthesia—Fluorouracil—colon cancer	3.98e-05	0.000519	CcSEcCtD
Paclitaxel—Pancreatitis—Methotrexate—colon cancer	3.97e-05	0.000518	CcSEcCtD
Paclitaxel—Constipation—Irinotecan—colon cancer	3.96e-05	0.000516	CcSEcCtD
Paclitaxel—Pain—Irinotecan—colon cancer	3.96e-05	0.000516	CcSEcCtD
Paclitaxel—Angiopathy—Capecitabine—colon cancer	3.96e-05	0.000515	CcSEcCtD
Paclitaxel—Dyspnoea—Fluorouracil—colon cancer	3.95e-05	0.000515	CcSEcCtD
Paclitaxel—Somnolence—Fluorouracil—colon cancer	3.94e-05	0.000513	CcSEcCtD
Paclitaxel—Immune system disorder—Capecitabine—colon cancer	3.94e-05	0.000513	CcSEcCtD
Paclitaxel—Mediastinal disorder—Capecitabine—colon cancer	3.93e-05	0.000512	CcSEcCtD
Paclitaxel—Chills—Capecitabine—colon cancer	3.91e-05	0.00051	CcSEcCtD
Paclitaxel—Dyspepsia—Fluorouracil—colon cancer	3.9e-05	0.000508	CcSEcCtD
Paclitaxel—Arrhythmia—Capecitabine—colon cancer	3.89e-05	0.000507	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Vincristine—colon cancer	3.89e-05	0.000506	CcSEcCtD
Paclitaxel—Decreased appetite—Fluorouracil—colon cancer	3.85e-05	0.000502	CcSEcCtD
Paclitaxel—Alopecia—Capecitabine—colon cancer	3.85e-05	0.000502	CcSEcCtD
Paclitaxel—Pancytopenia—Methotrexate—colon cancer	3.85e-05	0.000502	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Fluorouracil—colon cancer	3.83e-05	0.000499	CcSEcCtD
Paclitaxel—Mental disorder—Capecitabine—colon cancer	3.82e-05	0.000498	CcSEcCtD
Paclitaxel—Feeling abnormal—Irinotecan—colon cancer	3.81e-05	0.000497	CcSEcCtD
Paclitaxel—Erythema—Capecitabine—colon cancer	3.79e-05	0.000494	CcSEcCtD
Paclitaxel—Malnutrition—Capecitabine—colon cancer	3.79e-05	0.000494	CcSEcCtD
Paclitaxel—Dysuria—Methotrexate—colon cancer	3.79e-05	0.000494	CcSEcCtD
Paclitaxel—Neutropenia—Methotrexate—colon cancer	3.79e-05	0.000494	CcSEcCtD
Paclitaxel—Pain—Fluorouracil—colon cancer	3.79e-05	0.000494	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Irinotecan—colon cancer	3.78e-05	0.000493	CcSEcCtD
Paclitaxel—Upper respiratory tract infection—Methotrexate—colon cancer	3.77e-05	0.000491	CcSEcCtD
Paclitaxel—Abdominal pain—Vincristine—colon cancer	3.76e-05	0.000489	CcSEcCtD
Paclitaxel—Body temperature increased—Vincristine—colon cancer	3.76e-05	0.000489	CcSEcCtD
Paclitaxel—Flatulence—Capecitabine—colon cancer	3.74e-05	0.000487	CcSEcCtD
Paclitaxel—Dysgeusia—Capecitabine—colon cancer	3.72e-05	0.000484	CcSEcCtD
Paclitaxel—Photosensitivity reaction—Methotrexate—colon cancer	3.7e-05	0.000482	CcSEcCtD
Paclitaxel—Back pain—Capecitabine—colon cancer	3.67e-05	0.000478	CcSEcCtD
Paclitaxel—Abdominal pain—Irinotecan—colon cancer	3.66e-05	0.000477	CcSEcCtD
Paclitaxel—Body temperature increased—Irinotecan—colon cancer	3.66e-05	0.000477	CcSEcCtD
Paclitaxel—Feeling abnormal—Fluorouracil—colon cancer	3.65e-05	0.000476	CcSEcCtD
Paclitaxel—Muscle spasms—Capecitabine—colon cancer	3.65e-05	0.000475	CcSEcCtD
Paclitaxel—Pneumonia—Methotrexate—colon cancer	3.64e-05	0.000474	CcSEcCtD
Paclitaxel—Infestation NOS—Methotrexate—colon cancer	3.61e-05	0.000471	CcSEcCtD
Paclitaxel—Infestation—Methotrexate—colon cancer	3.61e-05	0.000471	CcSEcCtD
Paclitaxel—Depression—Methotrexate—colon cancer	3.6e-05	0.00047	CcSEcCtD
Paclitaxel—Stevens-Johnson syndrome—Methotrexate—colon cancer	3.58e-05	0.000467	CcSEcCtD
Paclitaxel—Vision blurred—Capecitabine—colon cancer	3.58e-05	0.000466	CcSEcCtD
Paclitaxel—Tremor—Capecitabine—colon cancer	3.56e-05	0.000463	CcSEcCtD
Paclitaxel—Renal failure—Methotrexate—colon cancer	3.55e-05	0.000463	CcSEcCtD
Paclitaxel—Stomatitis—Methotrexate—colon cancer	3.52e-05	0.000459	CcSEcCtD
Paclitaxel—Ill-defined disorder—Capecitabine—colon cancer	3.52e-05	0.000459	CcSEcCtD
Paclitaxel—Urticaria—Fluorouracil—colon cancer	3.52e-05	0.000459	CcSEcCtD
Paclitaxel—Conjunctivitis—Methotrexate—colon cancer	3.51e-05	0.000458	CcSEcCtD
Paclitaxel—Anaemia—Capecitabine—colon cancer	3.51e-05	0.000457	CcSEcCtD
Paclitaxel—Body temperature increased—Fluorouracil—colon cancer	3.5e-05	0.000457	CcSEcCtD
Paclitaxel—Hypersensitivity—Vincristine—colon cancer	3.5e-05	0.000456	CcSEcCtD
Paclitaxel—Haematuria—Methotrexate—colon cancer	3.45e-05	0.000449	CcSEcCtD
Paclitaxel—Malaise—Capecitabine—colon cancer	3.42e-05	0.000446	CcSEcCtD
Paclitaxel—Hepatobiliary disease—Methotrexate—colon cancer	3.42e-05	0.000445	CcSEcCtD
Paclitaxel—Epistaxis—Methotrexate—colon cancer	3.41e-05	0.000444	CcSEcCtD
Paclitaxel—Vertigo—Capecitabine—colon cancer	3.41e-05	0.000444	CcSEcCtD
Paclitaxel—Hypersensitivity—Irinotecan—colon cancer	3.41e-05	0.000444	CcSEcCtD
Paclitaxel—Asthenia—Vincristine—colon cancer	3.41e-05	0.000444	CcSEcCtD
Paclitaxel—Syncope—Capecitabine—colon cancer	3.4e-05	0.000443	CcSEcCtD
Paclitaxel—Leukopenia—Capecitabine—colon cancer	3.4e-05	0.000443	CcSEcCtD
Paclitaxel—Palpitations—Capecitabine—colon cancer	3.35e-05	0.000437	CcSEcCtD
Paclitaxel—Loss of consciousness—Capecitabine—colon cancer	3.34e-05	0.000435	CcSEcCtD
Paclitaxel—Asthenia—Irinotecan—colon cancer	3.32e-05	0.000433	CcSEcCtD
Paclitaxel—Cough—Capecitabine—colon cancer	3.31e-05	0.000431	CcSEcCtD
Paclitaxel—ABCB1—lymph node—colon cancer	3.31e-05	0.0011	CbGeAlD
Paclitaxel—Hypertension—Capecitabine—colon cancer	3.28e-05	0.000427	CcSEcCtD
Paclitaxel—Hypersensitivity—Fluorouracil—colon cancer	3.27e-05	0.000425	CcSEcCtD
Paclitaxel—Haemoglobin—Methotrexate—colon cancer	3.26e-05	0.000425	CcSEcCtD
Paclitaxel—Diarrhoea—Vincristine—colon cancer	3.25e-05	0.000424	CcSEcCtD
Paclitaxel—Haemorrhage—Methotrexate—colon cancer	3.25e-05	0.000423	CcSEcCtD
Paclitaxel—Myalgia—Capecitabine—colon cancer	3.23e-05	0.000421	CcSEcCtD
Paclitaxel—Chest pain—Capecitabine—colon cancer	3.23e-05	0.000421	CcSEcCtD
Paclitaxel—Arthralgia—Capecitabine—colon cancer	3.23e-05	0.000421	CcSEcCtD
Paclitaxel—Pharyngitis—Methotrexate—colon cancer	3.22e-05	0.00042	CcSEcCtD
Paclitaxel—Anxiety—Capecitabine—colon cancer	3.22e-05	0.00042	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	3.21e-05	0.000418	CcSEcCtD
Paclitaxel—Urinary tract disorder—Methotrexate—colon cancer	3.2e-05	0.000418	CcSEcCtD
Paclitaxel—Discomfort—Capecitabine—colon cancer	3.19e-05	0.000416	CcSEcCtD
Paclitaxel—Urethral disorder—Methotrexate—colon cancer	3.18e-05	0.000415	CcSEcCtD
Paclitaxel—Diarrhoea—Irinotecan—colon cancer	3.17e-05	0.000413	CcSEcCtD
Paclitaxel—Dry mouth—Capecitabine—colon cancer	3.16e-05	0.000412	CcSEcCtD
Paclitaxel—Dizziness—Vincristine—colon cancer	3.14e-05	0.000409	CcSEcCtD
Paclitaxel—Pruritus—Fluorouracil—colon cancer	3.14e-05	0.000409	CcSEcCtD
Paclitaxel—Visual impairment—Methotrexate—colon cancer	3.13e-05	0.000408	CcSEcCtD
Paclitaxel—Confusional state—Capecitabine—colon cancer	3.12e-05	0.000407	CcSEcCtD
Paclitaxel—Oedema—Capecitabine—colon cancer	3.1e-05	0.000404	CcSEcCtD
Paclitaxel—Infection—Capecitabine—colon cancer	3.08e-05	0.000401	CcSEcCtD
Paclitaxel—Erythema multiforme—Methotrexate—colon cancer	3.07e-05	0.0004	CcSEcCtD
Paclitaxel—Dizziness—Irinotecan—colon cancer	3.06e-05	0.000399	CcSEcCtD
Paclitaxel—Shock—Capecitabine—colon cancer	3.05e-05	0.000397	CcSEcCtD
Paclitaxel—Nervous system disorder—Capecitabine—colon cancer	3.04e-05	0.000396	CcSEcCtD
Paclitaxel—Eye disorder—Methotrexate—colon cancer	3.03e-05	0.000395	CcSEcCtD
Paclitaxel—Diarrhoea—Fluorouracil—colon cancer	3.03e-05	0.000395	CcSEcCtD
Paclitaxel—Thrombocytopenia—Capecitabine—colon cancer	3.03e-05	0.000395	CcSEcCtD
Paclitaxel—Tinnitus—Methotrexate—colon cancer	3.03e-05	0.000394	CcSEcCtD
Paclitaxel—Tachycardia—Capecitabine—colon cancer	3.02e-05	0.000394	CcSEcCtD
Paclitaxel—Vomiting—Vincristine—colon cancer	3.02e-05	0.000394	CcSEcCtD
Paclitaxel—Cardiac disorder—Methotrexate—colon cancer	3.01e-05	0.000392	CcSEcCtD
Paclitaxel—Skin disorder—Capecitabine—colon cancer	3.01e-05	0.000392	CcSEcCtD
Paclitaxel—Rash—Vincristine—colon cancer	3e-05	0.00039	CcSEcCtD
Paclitaxel—Hyperhidrosis—Capecitabine—colon cancer	2.99e-05	0.00039	CcSEcCtD
Paclitaxel—Dermatitis—Vincristine—colon cancer	2.99e-05	0.00039	CcSEcCtD
Paclitaxel—Headache—Vincristine—colon cancer	2.98e-05	0.000388	CcSEcCtD
Paclitaxel—Anorexia—Capecitabine—colon cancer	2.95e-05	0.000385	CcSEcCtD
Paclitaxel—Angiopathy—Methotrexate—colon cancer	2.94e-05	0.000384	CcSEcCtD
Paclitaxel—Vomiting—Irinotecan—colon cancer	2.94e-05	0.000383	CcSEcCtD
Paclitaxel—Immune system disorder—Methotrexate—colon cancer	2.93e-05	0.000382	CcSEcCtD
Paclitaxel—Dizziness—Fluorouracil—colon cancer	2.93e-05	0.000382	CcSEcCtD
Paclitaxel—Mediastinal disorder—Methotrexate—colon cancer	2.92e-05	0.000381	CcSEcCtD
Paclitaxel—Rash—Irinotecan—colon cancer	2.92e-05	0.00038	CcSEcCtD
Paclitaxel—Dermatitis—Irinotecan—colon cancer	2.91e-05	0.00038	CcSEcCtD
Paclitaxel—Chills—Methotrexate—colon cancer	2.91e-05	0.000379	CcSEcCtD
Paclitaxel—Headache—Irinotecan—colon cancer	2.9e-05	0.000378	CcSEcCtD
Paclitaxel—Hypotension—Capecitabine—colon cancer	2.89e-05	0.000377	CcSEcCtD
Paclitaxel—Alopecia—Methotrexate—colon cancer	2.87e-05	0.000374	CcSEcCtD
Paclitaxel—Mental disorder—Methotrexate—colon cancer	2.84e-05	0.00037	CcSEcCtD
Paclitaxel—Malnutrition—Methotrexate—colon cancer	2.82e-05	0.000368	CcSEcCtD
Paclitaxel—Erythema—Methotrexate—colon cancer	2.82e-05	0.000368	CcSEcCtD
Paclitaxel—Nausea—Vincristine—colon cancer	2.82e-05	0.000368	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Capecitabine—colon cancer	2.82e-05	0.000368	CcSEcCtD
Paclitaxel—Vomiting—Fluorouracil—colon cancer	2.82e-05	0.000367	CcSEcCtD
Paclitaxel—Insomnia—Capecitabine—colon cancer	2.8e-05	0.000365	CcSEcCtD
Paclitaxel—Rash—Fluorouracil—colon cancer	2.79e-05	0.000364	CcSEcCtD
Paclitaxel—Dermatitis—Fluorouracil—colon cancer	2.79e-05	0.000364	CcSEcCtD
Paclitaxel—Paraesthesia—Capecitabine—colon cancer	2.78e-05	0.000362	CcSEcCtD
Paclitaxel—Headache—Fluorouracil—colon cancer	2.78e-05	0.000362	CcSEcCtD
Paclitaxel—Dysgeusia—Methotrexate—colon cancer	2.77e-05	0.00036	CcSEcCtD
Paclitaxel—Dyspnoea—Capecitabine—colon cancer	2.76e-05	0.00036	CcSEcCtD
Paclitaxel—Nausea—Irinotecan—colon cancer	2.75e-05	0.000358	CcSEcCtD
Paclitaxel—Back pain—Methotrexate—colon cancer	2.73e-05	0.000356	CcSEcCtD
Paclitaxel—Dyspepsia—Capecitabine—colon cancer	2.73e-05	0.000355	CcSEcCtD
Paclitaxel—Decreased appetite—Capecitabine—colon cancer	2.69e-05	0.000351	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Capecitabine—colon cancer	2.67e-05	0.000348	CcSEcCtD
Paclitaxel—Fatigue—Capecitabine—colon cancer	2.67e-05	0.000348	CcSEcCtD
Paclitaxel—Vision blurred—Methotrexate—colon cancer	2.66e-05	0.000347	CcSEcCtD
Paclitaxel—Pain—Capecitabine—colon cancer	2.65e-05	0.000345	CcSEcCtD
Paclitaxel—Constipation—Capecitabine—colon cancer	2.65e-05	0.000345	CcSEcCtD
Paclitaxel—Nausea—Fluorouracil—colon cancer	2.63e-05	0.000343	CcSEcCtD
Paclitaxel—Ill-defined disorder—Methotrexate—colon cancer	2.62e-05	0.000342	CcSEcCtD
Paclitaxel—Anaemia—Methotrexate—colon cancer	2.61e-05	0.00034	CcSEcCtD
Paclitaxel—Feeling abnormal—Capecitabine—colon cancer	2.55e-05	0.000333	CcSEcCtD
Paclitaxel—Malaise—Methotrexate—colon cancer	2.55e-05	0.000332	CcSEcCtD
Paclitaxel—Vertigo—Methotrexate—colon cancer	2.54e-05	0.000331	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Capecitabine—colon cancer	2.53e-05	0.00033	CcSEcCtD
Paclitaxel—Leukopenia—Methotrexate—colon cancer	2.53e-05	0.000329	CcSEcCtD
Paclitaxel—Cough—Methotrexate—colon cancer	2.47e-05	0.000321	CcSEcCtD
Paclitaxel—Urticaria—Capecitabine—colon cancer	2.46e-05	0.000321	CcSEcCtD
Paclitaxel—Abdominal pain—Capecitabine—colon cancer	2.45e-05	0.000319	CcSEcCtD
Paclitaxel—Body temperature increased—Capecitabine—colon cancer	2.45e-05	0.000319	CcSEcCtD
Paclitaxel—Convulsion—Methotrexate—colon cancer	2.45e-05	0.000319	CcSEcCtD
Paclitaxel—Arthralgia—Methotrexate—colon cancer	2.41e-05	0.000313	CcSEcCtD
Paclitaxel—Chest pain—Methotrexate—colon cancer	2.41e-05	0.000313	CcSEcCtD
Paclitaxel—Myalgia—Methotrexate—colon cancer	2.41e-05	0.000313	CcSEcCtD
Paclitaxel—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	2.39e-05	0.000311	CcSEcCtD
Paclitaxel—Discomfort—Methotrexate—colon cancer	2.38e-05	0.00031	CcSEcCtD
Paclitaxel—Confusional state—Methotrexate—colon cancer	2.32e-05	0.000303	CcSEcCtD
Paclitaxel—Anaphylactic shock—Methotrexate—colon cancer	2.31e-05	0.0003	CcSEcCtD
Paclitaxel—Infection—Methotrexate—colon cancer	2.29e-05	0.000298	CcSEcCtD
Paclitaxel—Hypersensitivity—Capecitabine—colon cancer	2.28e-05	0.000297	CcSEcCtD
Paclitaxel—Nervous system disorder—Methotrexate—colon cancer	2.26e-05	0.000295	CcSEcCtD
Paclitaxel—Thrombocytopenia—Methotrexate—colon cancer	2.26e-05	0.000294	CcSEcCtD
Paclitaxel—Skin disorder—Methotrexate—colon cancer	2.24e-05	0.000292	CcSEcCtD
Paclitaxel—Hyperhidrosis—Methotrexate—colon cancer	2.23e-05	0.00029	CcSEcCtD
Paclitaxel—Asthenia—Capecitabine—colon cancer	2.22e-05	0.00029	CcSEcCtD
Paclitaxel—Anorexia—Methotrexate—colon cancer	2.2e-05	0.000286	CcSEcCtD
Paclitaxel—Pruritus—Capecitabine—colon cancer	2.19e-05	0.000286	CcSEcCtD
Paclitaxel—Hypotension—Methotrexate—colon cancer	2.15e-05	0.000281	CcSEcCtD
Paclitaxel—Diarrhoea—Capecitabine—colon cancer	2.12e-05	0.000276	CcSEcCtD
Paclitaxel—Musculoskeletal discomfort—Methotrexate—colon cancer	2.1e-05	0.000274	CcSEcCtD
Paclitaxel—Insomnia—Methotrexate—colon cancer	2.09e-05	0.000272	CcSEcCtD
Paclitaxel—Paraesthesia—Methotrexate—colon cancer	2.07e-05	0.00027	CcSEcCtD
Paclitaxel—Dyspnoea—Methotrexate—colon cancer	2.06e-05	0.000268	CcSEcCtD
Paclitaxel—Somnolence—Methotrexate—colon cancer	2.05e-05	0.000267	CcSEcCtD
Paclitaxel—Dizziness—Capecitabine—colon cancer	2.05e-05	0.000267	CcSEcCtD
Paclitaxel—Dyspepsia—Methotrexate—colon cancer	2.03e-05	0.000264	CcSEcCtD
Paclitaxel—Decreased appetite—Methotrexate—colon cancer	2e-05	0.000261	CcSEcCtD
Paclitaxel—Gastrointestinal disorder—Methotrexate—colon cancer	1.99e-05	0.000259	CcSEcCtD
Paclitaxel—Fatigue—Methotrexate—colon cancer	1.99e-05	0.000259	CcSEcCtD
Paclitaxel—Pain—Methotrexate—colon cancer	1.97e-05	0.000257	CcSEcCtD
Paclitaxel—Vomiting—Capecitabine—colon cancer	1.97e-05	0.000257	CcSEcCtD
Paclitaxel—Rash—Capecitabine—colon cancer	1.95e-05	0.000254	CcSEcCtD
Paclitaxel—Dermatitis—Capecitabine—colon cancer	1.95e-05	0.000254	CcSEcCtD
Paclitaxel—Headache—Capecitabine—colon cancer	1.94e-05	0.000253	CcSEcCtD
Paclitaxel—Feeling abnormal—Methotrexate—colon cancer	1.9e-05	0.000248	CcSEcCtD
Paclitaxel—Gastrointestinal pain—Methotrexate—colon cancer	1.89e-05	0.000246	CcSEcCtD
Paclitaxel—Nausea—Capecitabine—colon cancer	1.84e-05	0.00024	CcSEcCtD
Paclitaxel—Urticaria—Methotrexate—colon cancer	1.83e-05	0.000239	CcSEcCtD
Paclitaxel—Abdominal pain—Methotrexate—colon cancer	1.82e-05	0.000237	CcSEcCtD
Paclitaxel—Body temperature increased—Methotrexate—colon cancer	1.82e-05	0.000237	CcSEcCtD
Paclitaxel—Hypersensitivity—Methotrexate—colon cancer	1.7e-05	0.000221	CcSEcCtD
Paclitaxel—Asthenia—Methotrexate—colon cancer	1.65e-05	0.000216	CcSEcCtD
Paclitaxel—Pruritus—Methotrexate—colon cancer	1.63e-05	0.000213	CcSEcCtD
Paclitaxel—Diarrhoea—Methotrexate—colon cancer	1.58e-05	0.000206	CcSEcCtD
Paclitaxel—Dizziness—Methotrexate—colon cancer	1.52e-05	0.000199	CcSEcCtD
Paclitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—colon cancer	1.51e-05	0.000413	CbGpPWpGaD
Paclitaxel—SLCO1B3—Transmembrane transport of small molecules—ABCB1—colon cancer	1.5e-05	0.000409	CbGpPWpGaD
Paclitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	1.49e-05	0.000408	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CA7—colon cancer	1.47e-05	0.000403	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EP300—colon cancer	1.47e-05	0.000402	CbGpPWpGaD
Paclitaxel—Vomiting—Methotrexate—colon cancer	1.47e-05	0.000191	CcSEcCtD
Paclitaxel—Rash—Methotrexate—colon cancer	1.45e-05	0.000189	CcSEcCtD
Paclitaxel—Dermatitis—Methotrexate—colon cancer	1.45e-05	0.000189	CcSEcCtD
Paclitaxel—Headache—Methotrexate—colon cancer	1.44e-05	0.000188	CcSEcCtD
Paclitaxel—BCL2—Innate Immune System—BCL2L1—colon cancer	1.44e-05	0.000394	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—PIK3CA—colon cancer	1.44e-05	0.000393	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.43e-05	0.000391	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Breast Cancer Pathway—AKT1—colon cancer	1.41e-05	0.000386	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—colon cancer	1.39e-05	0.000381	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.38e-05	0.000378	CbGpPWpGaD
Paclitaxel—BCL2—Apoptosis—AKT1—colon cancer	1.38e-05	0.000378	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—FGFR3—colon cancer	1.38e-05	0.000377	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CA7—colon cancer	1.38e-05	0.000376	CbGpPWpGaD
Paclitaxel—Nausea—Methotrexate—colon cancer	1.37e-05	0.000178	CcSEcCtD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	1.35e-05	0.000369	CbGpPWpGaD
Paclitaxel—NR1I2—Generic Transcription Pathway—MYC—colon cancer	1.33e-05	0.000364	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—HRAS—colon cancer	1.33e-05	0.000364	CbGpPWpGaD
Paclitaxel—ABCC2—NRF2 pathway—TGFB1—colon cancer	1.32e-05	0.000362	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CCND1—colon cancer	1.32e-05	0.00036	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—CASP3—colon cancer	1.3e-05	0.000357	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—MYC—colon cancer	1.28e-05	0.00035	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	1.28e-05	0.00035	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.27e-05	0.000349	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—EGFR—colon cancer	1.25e-05	0.000343	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	1.24e-05	0.000341	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—EP300—colon cancer	1.21e-05	0.000332	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	1.2e-05	0.000328	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—KRAS—colon cancer	1.18e-05	0.000324	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—CHST5—colon cancer	1.18e-05	0.000323	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ODC1—colon cancer	1.18e-05	0.000323	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CCND1—colon cancer	1.18e-05	0.000322	CbGpPWpGaD
Paclitaxel—BCL2—Focal Adhesion—AKT1—colon cancer	1.17e-05	0.000321	CbGpPWpGaD
Paclitaxel—BCL2—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.17e-05	0.00032	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—CDKN1A—colon cancer	1.14e-05	0.000312	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—PPARG—colon cancer	1.12e-05	0.000307	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—VEGFA—colon cancer	1.11e-05	0.000303	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.09e-05	0.000299	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—colon cancer	1.09e-05	0.000299	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—EP300—colon cancer	1.08e-05	0.000297	CbGpPWpGaD
Paclitaxel—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	1.07e-05	0.000293	CbGpPWpGaD
Paclitaxel—ABCC1—Transmembrane transport of small molecules—ABCB1—colon cancer	1.06e-05	0.000289	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle, Mitotic—MYC—colon cancer	1.06e-05	0.000289	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—CDKN1A—colon cancer	1.06e-05	0.000289	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—TP53—colon cancer	1.05e-05	0.000288	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.03e-05	0.000282	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—CHST5—colon cancer	1.02e-05	0.00028	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ODC1—colon cancer	1.02e-05	0.00028	CbGpPWpGaD
Paclitaxel—ABCB1—Allograft Rejection—TGFB1—colon cancer	1.02e-05	0.000278	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—EP300—colon cancer	1e-05	0.000275	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—colon cancer	9.98e-06	0.000273	CbGpPWpGaD
Paclitaxel—TUBB2B—Metabolism of proteins—CTNNB1—colon cancer	9.81e-06	0.000268	CbGpPWpGaD
Paclitaxel—TUBB6—Metabolism of proteins—CTNNB1—colon cancer	9.81e-06	0.000268	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CD8A—colon cancer	9.81e-06	0.000268	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CCND1—colon cancer	9.76e-06	0.000267	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—CDKN1A—colon cancer	9.66e-06	0.000264	CbGpPWpGaD
Paclitaxel—TUBB3—Metabolism of proteins—CTNNB1—colon cancer	9.48e-06	0.000259	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—MYC—colon cancer	9.45e-06	0.000258	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—CDKN1A—colon cancer	9.44e-06	0.000258	CbGpPWpGaD
Paclitaxel—ABCG2—Transmembrane transport of small molecules—ABCB1—colon cancer	9.31e-06	0.000255	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—EP300—colon cancer	9.19e-06	0.000251	CbGpPWpGaD
Paclitaxel—TUBB2A—Metabolism of proteins—CTNNB1—colon cancer	9.18e-06	0.000251	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	9.14e-06	0.00025	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CA7—colon cancer	9.07e-06	0.000248	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—EP300—colon cancer	8.98e-06	0.000246	CbGpPWpGaD
Paclitaxel—TUBB1—Metabolism of proteins—CTNNB1—colon cancer	8.97e-06	0.000246	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CCND1—colon cancer	8.93e-06	0.000244	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—CHST5—colon cancer	8.92e-06	0.000244	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—ODC1—colon cancer	8.92e-06	0.000244	CbGpPWpGaD
Paclitaxel—CYP19A1—Integrated Breast Cancer Pathway—AKT1—colon cancer	8.88e-06	0.000243	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle, Mitotic—MYC—colon cancer	8.76e-06	0.00024	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—CDKN1A—colon cancer	8.64e-06	0.000236	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.61e-06	0.000236	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CTNNB1—colon cancer	8.59e-06	0.000235	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—CDKN1A—colon cancer	8.39e-06	0.00023	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—BCL2L1—colon cancer	8.39e-06	0.00023	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—CHST5—colon cancer	8.33e-06	0.000228	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ODC1—colon cancer	8.33e-06	0.000228	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—EP300—colon cancer	8.22e-06	0.000225	CbGpPWpGaD
Paclitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	8.16e-06	0.000223	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	8.1e-06	0.000222	CbGpPWpGaD
Paclitaxel—TUBB4A—Metabolism of proteins—CTNNB1—colon cancer	8.06e-06	0.00022	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—FGFR3—colon cancer	8.02e-06	0.000219	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle, Mitotic—MYC—colon cancer	8.01e-06	0.000219	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EP300—colon cancer	7.98e-06	0.000218	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—MYC—colon cancer	7.83e-06	0.000214	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.77e-06	0.000213	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—SRC—colon cancer	7.76e-06	0.000212	CbGpPWpGaD
Paclitaxel—TUBB—Cell Cycle—TP53—colon cancer	7.76e-06	0.000212	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.74e-06	0.000212	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	7.49e-06	0.000205	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—NRAS—colon cancer	7.47e-06	0.000204	CbGpPWpGaD
Paclitaxel—TUBB4B—Metabolism of proteins—CTNNB1—colon cancer	7.37e-06	0.000202	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.16e-06	0.000196	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—MYC—colon cancer	7.16e-06	0.000196	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—ABCB1—colon cancer	7.01e-06	0.000192	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	6.94e-06	0.00019	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—TYMS—colon cancer	6.88e-06	0.000188	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—EGFR—colon cancer	6.8e-06	0.000186	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDH1—colon cancer	6.78e-06	0.000185	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—EP300—colon cancer	6.74e-06	0.000184	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—ABCB1—colon cancer	6.59e-06	0.00018	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—TYMS—colon cancer	6.48e-06	0.000177	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	6.44e-06	0.000176	CbGpPWpGaD
Paclitaxel—TUBB4A—Cell Cycle—TP53—colon cancer	6.43e-06	0.000176	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—KRAS—colon cancer	6.43e-06	0.000176	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—MYC—colon cancer	6.4e-06	0.000175	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	6.27e-06	0.000171	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	6.21e-06	0.00017	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.12e-06	0.000167	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	6.09e-06	0.000167	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	6.06e-06	0.000166	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—PIK3CA—colon cancer	5.91e-06	0.000162	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	5.89e-06	0.000161	CbGpPWpGaD
Paclitaxel—TUBB4B—Cell Cycle—TP53—colon cancer	5.88e-06	0.000161	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	5.77e-06	0.000158	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	5.61e-06	0.000153	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ODC1—colon cancer	5.5e-06	0.00015	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—CHST5—colon cancer	5.5e-06	0.00015	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	5.46e-06	0.000149	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—HRAS—colon cancer	5.46e-06	0.000149	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.3e-06	0.000145	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.09e-06	0.000139	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—EP300—colon cancer	5.06e-06	0.000139	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	5.03e-06	0.000138	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	5.01e-06	0.000137	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CTNNB1—colon cancer	5e-06	0.000137	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	4.99e-06	0.000136	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—ABCB1—colon cancer	4.98e-06	0.000136	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—ABCB1—colon cancer	4.95e-06	0.000136	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	4.92e-06	0.000135	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	4.9e-06	0.000134	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—TYMS—colon cancer	4.89e-06	0.000134	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—CDKN1A—colon cancer	4.89e-06	0.000134	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PPARG—colon cancer	4.88e-06	0.000133	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—TYMS—colon cancer	4.87e-06	0.000133	CbGpPWpGaD
Paclitaxel—BCL2—Innate Immune System—AKT1—colon cancer	4.82e-06	0.000132	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—ABCB1—colon cancer	4.79e-06	0.000131	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—TYMS—colon cancer	4.71e-06	0.000129	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EP300—colon cancer	4.65e-06	0.000127	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	4.65e-06	0.000127	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—FGFR3—colon cancer	4.64e-06	0.000127	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PPARG—colon cancer	4.59e-06	0.000126	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—SRC—colon cancer	4.52e-06	0.000124	CbGpPWpGaD
Paclitaxel—NR1I2—Gene Expression—AKT1—colon cancer	4.44e-06	0.000121	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—ABCB1—colon cancer	4.36e-06	0.000119	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—NRAS—colon cancer	4.35e-06	0.000119	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—ABCB1—colon cancer	4.32e-06	0.000118	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—TYMS—colon cancer	4.28e-06	0.000117	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	4.27e-06	0.000117	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—APC—colon cancer	4.26e-06	0.000117	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—TYMS—colon cancer	4.24e-06	0.000116	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.23e-06	0.000116	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	4.13e-06	0.000113	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—BRAF—colon cancer	4.01e-06	0.00011	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—EGFR—colon cancer	3.96e-06	0.000108	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PTGS2—colon cancer	3.84e-06	0.000105	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.76e-06	0.000103	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.75e-06	0.000102	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—KRAS—colon cancer	3.74e-06	0.000102	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	3.62e-06	9.91e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PTGS2—colon cancer	3.61e-06	9.87e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	3.49e-06	9.54e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PPARG—colon cancer	3.46e-06	9.47e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PPARG—colon cancer	3.45e-06	9.43e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	3.44e-06	9.41e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—PIK3CA—colon cancer	3.44e-06	9.41e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PPARG—colon cancer	3.33e-06	9.12e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.32e-06	9.1e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PTGS2—colon cancer	3.24e-06	8.86e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—EP300—colon cancer	3.19e-06	8.73e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—HRAS—colon cancer	3.18e-06	8.71e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—ABCB1—colon cancer	3.12e-06	8.55e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—TYMS—colon cancer	3.07e-06	8.39e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PPARG—colon cancer	3.03e-06	8.3e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PPARG—colon cancer	3.01e-06	8.22e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—EP300—colon cancer	3e-06	8.21e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CTNNB1—colon cancer	2.9e-06	7.93e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—CDKN1A—colon cancer	2.83e-06	7.74e-05	CbGpPWpGaD
Paclitaxel—BCL2—Immune System—AKT1—colon cancer	2.81e-06	7.69e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.77e-06	7.56e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PTGS2—colon cancer	2.72e-06	7.45e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PTGS2—colon cancer	2.71e-06	7.42e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.71e-06	7.4e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—ABCB1—colon cancer	2.71e-06	7.4e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EP300—colon cancer	2.69e-06	7.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—TYMS—colon cancer	2.66e-06	7.27e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PTGS2—colon cancer	2.62e-06	7.17e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—SRC—colon cancer	2.62e-06	7.16e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—NRAS—colon cancer	2.52e-06	6.89e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PTGS2—colon cancer	2.39e-06	6.53e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PTGS2—colon cancer	2.36e-06	6.47e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—PIK3CA—colon cancer	2.36e-06	6.46e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—MYC—colon cancer	2.35e-06	6.42e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—TGFB1—colon cancer	2.34e-06	6.4e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—TYMS—colon cancer	2.31e-06	6.33e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—EGFR—colon cancer	2.3e-06	6.28e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—EP300—colon cancer	2.26e-06	6.2e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—EP300—colon cancer	2.26e-06	6.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	2.25e-06	6.16e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—PIK3CA—colon cancer	2.22e-06	6.08e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—ABCB1—colon cancer	2.2e-06	6.02e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—EP300—colon cancer	2.18e-06	5.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PPARG—colon cancer	2.17e-06	5.95e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—KRAS—colon cancer	2.17e-06	5.93e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—TYMS—colon cancer	2.16e-06	5.92e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.05e-06	5.6e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—PIK3CA—colon cancer	1.99e-06	5.45e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—EP300—colon cancer	1.98e-06	5.43e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—EP300—colon cancer	1.97e-06	5.38e-05	CbGpPWpGaD
Paclitaxel—SLCO1B3—Metabolism—AKT1—colon cancer	1.93e-06	5.27e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PPARG—colon cancer	1.88e-06	5.15e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—HRAS—colon cancer	1.84e-06	5.04e-05	CbGpPWpGaD
Paclitaxel—ABCB11—Metabolism—AKT1—colon cancer	1.81e-06	4.96e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PTGS2—colon cancer	1.71e-06	4.68e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—PIK3CA—colon cancer	1.68e-06	4.58e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—PIK3CA—colon cancer	1.67e-06	4.56e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.66e-06	4.55e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PPARG—colon cancer	1.64e-06	4.49e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Disease—AKT1—colon cancer	1.63e-06	4.45e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—PIK3CA—colon cancer	1.61e-06	4.41e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PPARG—colon cancer	1.53e-06	4.19e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PTGS2—colon cancer	1.48e-06	4.05e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—PIK3CA—colon cancer	1.47e-06	4.02e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—PIK3CA—colon cancer	1.45e-06	3.98e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—ABCB1—colon cancer	1.45e-06	3.97e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—TYMS—colon cancer	1.43e-06	3.9e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—EP300—colon cancer	1.42e-06	3.89e-05	CbGpPWpGaD
Paclitaxel—CYP19A1—Metabolism—AKT1—colon cancer	1.37e-06	3.74e-05	CbGpPWpGaD
Paclitaxel—ABCC1—Metabolism—AKT1—colon cancer	1.36e-06	3.73e-05	CbGpPWpGaD
Paclitaxel—CYP1B1—Metabolism—AKT1—colon cancer	1.32e-06	3.61e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PTGS2—colon cancer	1.29e-06	3.53e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—EP300—colon cancer	1.23e-06	3.37e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PTGS2—colon cancer	1.21e-06	3.3e-05	CbGpPWpGaD
Paclitaxel—ABCG2—Metabolism—AKT1—colon cancer	1.2e-06	3.28e-05	CbGpPWpGaD
Paclitaxel—CYP3A7—Metabolism—AKT1—colon cancer	1.19e-06	3.25e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—EP300—colon cancer	1.07e-06	2.94e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—PIK3CA—colon cancer	1.05e-06	2.88e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PPARG—colon cancer	1.01e-06	2.76e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—EP300—colon cancer	1e-06	2.74e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—PIK3CA—colon cancer	9.11e-07	2.49e-05	CbGpPWpGaD
Paclitaxel—CYP3A5—Metabolism—AKT1—colon cancer	8.59e-07	2.35e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PTGS2—colon cancer	7.95e-07	2.17e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—PIK3CA—colon cancer	7.94e-07	2.17e-05	CbGpPWpGaD
Paclitaxel—CYP2C8—Metabolism—AKT1—colon cancer	7.44e-07	2.04e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—PIK3CA—colon cancer	7.41e-07	2.03e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—EP300—colon cancer	6.61e-07	1.81e-05	CbGpPWpGaD
Paclitaxel—ABCB1—Metabolism—AKT1—colon cancer	6.48e-07	1.77e-05	CbGpPWpGaD
Paclitaxel—CYP2C9—Metabolism—AKT1—colon cancer	6.06e-07	1.66e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—PIK3CA—colon cancer	4.89e-07	1.34e-05	CbGpPWpGaD
Paclitaxel—CYP3A4—Metabolism—AKT1—colon cancer	3.99e-07	1.09e-05	CbGpPWpGaD
